Vivani Medical (VANI) News Today $1.10 +0.01 (+0.92%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$1.10 0.00 (0.00%) As of 03/25/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025March 24 at 9:07 AM | businesswire.comVivani Medical (VANI) Expected to Announce Quarterly Earnings on TuesdayVivani Medical (NASDAQ:VANI) will be releasing earnings before the market opens on Tuesday, March 25, Financial Modeling Prep reports.March 18, 2025 | marketbeat.comFY2024 EPS Estimates for Vivani Medical Cut by HC WainwrightMarch 18, 2025 | americanbankingnews.comBrokers Offer Predictions for Vivani Medical FY2024 EarningsVivani Medical, Inc. (NASDAQ:VANI - Free Report) - HC Wainwright dropped their FY2024 earnings per share (EPS) estimates for Vivani Medical in a note issued to investors on Thursday, March 13th. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings of ($0.43) per share fMarch 17, 2025 | marketbeat.comVivani Medical (NASDAQ:VANI) Given "Buy" Rating at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $4.00 price target on shares of Vivani Medical in a research note on Thursday.March 14, 2025 | marketbeat.comVivani Medical Stock Short Interest Report | NASDAQ:VANI | BenzingaMarch 14, 2025 | benzinga.comVivani Medical announces 1st GLP-1 implant in Liberate-1 clinical trialMarch 13, 2025 | markets.businessinsider.comVivani Medical to spin-off neurostim business Cortigent as public companyMarch 13, 2025 | msn.comVivani treats first patient with long-lasting drug implant for weight lossMarch 13, 2025 | finance.yahoo.comVivani Medical Achieves 1st Implant & Full Enrollment in Overweight TrialMarch 13, 2025 | finance.yahoo.comVivani Medical intends to spin off Cortigent divisionMarch 12, 2025 | markets.businessinsider.comVivani Medical to divest its neurostimulation devices businessMarch 12, 2025 | msn.comVivani Medical to Spin-Off Neurostimulation Division Cortigent for Nasdaq ListingMarch 12, 2025 | finance.yahoo.comVivani Medical Announces Intent to Spin Off Cortigent Neurostimulation BusinessMarch 12, 2025 | finance.yahoo.comEXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder ValueMarch 12, 2025 | benzinga.comShort Interest in Vivani Medical, Inc. (NASDAQ:VANI) Drops By 23.0%Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) was the recipient of a significant decrease in short interest in December. As of December 31st, there was short interest totalling 358,000 shares, a decrease of 23.0% from the December 15th total of 465,200 shares. Currently, 1.2% of the shares of the company are sold short. Based on an average daily trading volume, of 121,200 shares, the short-interest ratio is presently 3.0 days.January 15, 2025 | marketbeat.comVivani Medical: Strategic Innovation in GLP-1 Obesity Treatment Justifies Buy RatingDecember 22, 2024 | markets.businessinsider.comVivani begins exenatide implant trial for obesity in AustraliaDecember 20, 2024 | finance.yahoo.comVivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in AustraliaDecember 19, 2024 | finance.yahoo.comVivani Medical, Inc. (NASDAQ:VANI) Short Interest Down 29.6% in NovemberVivani Medical, Inc. (NASDAQ:VANI - Get Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 531,000 shares, a decline of 29.6% from the October 31st total of 754,400 shares. Based on an average trading volume of 100,300 shares, the short-interest ratio is presently 5.3 days. Currently, 1.9% of the shares of the company are sold short.November 29, 2024 | marketbeat.comVivani Medical Gains ‘Buy’ Rating Due to Strategic Advancements and Financial StrengthNovember 15, 2024 | markets.businessinsider.comVivani Medical Reports Q3 Loss, Advances GLP-1 TrialsNovember 14, 2024 | markets.businessinsider.comVivani Medical, Inc. (NASDAQ:VANI) Director Buys $4,999,998.78 in StockNovember 14, 2024 | insidertrades.comVivani Medical Secures Funding for GLP-1 Implant TrialNovember 14, 2024 | markets.businessinsider.comVivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | finance.yahoo.comVivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams Purchases 3,968,253 SharesVivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams acquired 3,968,253 shares of the company's stock in a transaction dated Friday, November 8th. The shares were bought at an average cost of $1.26 per share, with a total value of $4,999,998.78. Following the purchase, the director now owns 4,695,861 shares in the company, valued at approximately $5,916,784.86. The trade was a 500.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.November 13, 2024 | marketbeat.com3 US Penny Stocks To Monitor In October 2024October 23, 2024 | finance.yahoo.comVivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024October 23, 2024 | finance.yahoo.comVivani Medical (NASDAQ:VANI) Trading Up 0.9% - Time to Buy?Vivani Medical (NASDAQ:VANI) Stock Price Up 0.9% - What's Next?October 15, 2024 | marketbeat.comVivani Medical's implant trial gets Australian regulatory nodSeptember 28, 2024 | uk.investing.comBuy Rating on Vivani Medical: Advancing GLP-1 Therapies with Innovative Implantable TreatmentSeptember 28, 2024 | markets.businessinsider.comVivani Medical to Test Implant in Obese and Overweight PatientsSeptember 27, 2024 | finance.yahoo.comVivani Medical obtains Australian approval to begin GLP-1 implant trialSeptember 27, 2024 | finance.yahoo.comEXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in AustraliaSeptember 26, 2024 | benzinga.comBuy Rating Affirmed for Vivani Medical on Strong Potential of NPM-115 Implant for Metabolic Disease TreatmentSeptember 7, 2024 | markets.businessinsider.comVivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 ImplantSeptember 4, 2024 | finance.yahoo.comVivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceAugust 28, 2024 | finance.yahoo.comInnovative Obesity Treatment Promises High Compliance: Buy Recommendation for Vivani MedicalAugust 15, 2024 | markets.businessinsider.comHere's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn SituationAugust 14, 2024 | finance.yahoo.comVANI Stock Earnings: Vivani Medical Beats EPS for Q2 2024August 13, 2024 | markets.businessinsider.comVivani Medical Provides Business Update and Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 | finance.yahoo.comVivani Medical's chief business officer buys $1.92k in company stockAugust 3, 2024 | investing.comVivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug ImplantJune 13, 2024 | businesswire.comEXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary UseMay 28, 2024 | msn.comVivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 ImplantMay 28, 2024 | businesswire.comBuy Rating Justified: Vivani Medical’s Promising NPM-115 Implant and Strategic Market PositioningMay 16, 2024 | markets.businessinsider.comVANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024May 13, 2024 | investorplace.comVivani Medical Provides Business Update and Reports First Quarter 2024 Financial ResultsMay 13, 2024 | businesswire.comVivani Medical to Present at TIDES Conference 2024May 9, 2024 | finance.yahoo.comShort Interest in Vivani Medical, Inc. (NASDAQ:VANI) Expands By 420.1%Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 938,800 shares, an increase of 420.1% from the February 29th total of 180,500 shares. Based on an average daily volume of 2,970,000 shares, the days-to-cover ratio is currently 0.3 days. Currently, 3.4% of the shares of the stock are short sold.March 27, 2024 | marketbeat.com Remove Ads Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address VANI Media Mentions By Week VANI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VANI News Sentiment▼-0.190.79▲Average Medical News Sentiment VANI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VANI Articles This Week▼21▲VANI Articles Average Week Remove Ads Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RCEL News Today NVRO News Today ELMD News Today PROF News Today LAKE News Today INGN News Today DRTS News Today AVR News Today BWAY News Today SKIN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VANI) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VANI Stock Free VANI Stock Alerts